These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

822 related items for PubMed ID: 16573364

  • 21. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
    Arbyn M, Dillner J.
    J Clin Virol; 2007 Mar; 38(3):189-97. PubMed ID: 17258503
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia.
    Shi JF, Qiao YL, Smith JS, Dondog B, Bao YP, Dai M, Clifford GM, Franceschi S.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M53-9. PubMed ID: 18945414
    [Abstract] [Full Text] [Related]

  • 25. Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The Netherlands.
    Boot HJ, Wallenburg I, de Melker HE, Mangen MJ, Gerritsen AA, van der Maas NA, Berkhof J, Meijer CJ, Kimman TG.
    Vaccine; 2007 Aug 14; 25(33):6245-56. PubMed ID: 17630049
    [Abstract] [Full Text] [Related]

  • 26. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study.
    Dondog B, Clifford GM, Vaccarella S, Waterboer T, Unurjargal D, Avirmed D, Enkhtuya S, Kommoss F, Wentzensen N, Snijders PJ, Meijer CJ, Franceschi S, Pawlita M.
    Cancer Epidemiol Biomarkers Prev; 2008 Jul 14; 17(7):1731-8. PubMed ID: 18628425
    [Abstract] [Full Text] [Related]

  • 27. Integrating human papillomavirus vaccination in cervical cancer control programmes.
    Franco EL, Coutlée F, Ferenczy A.
    Public Health Genomics; 2009 Jul 14; 12(5-6):352-61. PubMed ID: 19684447
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.
    Harper DM.
    Public Health Genomics; 2009 Jul 14; 12(5-6):319-30. PubMed ID: 19684444
    [Abstract] [Full Text] [Related]

  • 30. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
    Bégué P, Henrion R, Blanc B, Girard M, Sancho-Garnier H.
    Bull Acad Natl Med; 2007 Dec 14; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
    [Abstract] [Full Text] [Related]

  • 31. Eligibility and willingness of young Icelandic women to participate in a HPV vaccination trial.
    Gudmundsdóttir T, Tryggvadóttir L, Allende M, Mast TC, Briem H, Sigurdsson K.
    Acta Obstet Gynecol Scand; 2003 Apr 14; 82(4):345-50. PubMed ID: 12716319
    [Abstract] [Full Text] [Related]

  • 32. The clinical benefit and cost-effectiveness of human papillomavirus vaccination for adult women in the Netherlands.
    Bogaards JA, Coupé VM, Meijer CJ, Berkhof J.
    Vaccine; 2011 Nov 08; 29(48):8929-36. PubMed ID: 21945961
    [Abstract] [Full Text] [Related]

  • 33. The current and future role of screening in the era of HPV vaccination.
    Myers E, Huh WK, Wright JD, Smith JS.
    Gynecol Oncol; 2008 May 08; 109(2 Suppl):S31-9. PubMed ID: 18482556
    [Abstract] [Full Text] [Related]

  • 34. Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control.
    Franco EL, Harper DM.
    Vaccine; 2005 Mar 18; 23(17-18):2388-94. PubMed ID: 15755633
    [Abstract] [Full Text] [Related]

  • 35. Prospects for cervical cancer prevention by human papillomavirus vaccination.
    Schiller JT, Lowy DR.
    Cancer Res; 2006 Nov 01; 66(21):10229-32. PubMed ID: 17079437
    [Abstract] [Full Text] [Related]

  • 36. New advances in vaccine technology and improved cervical cancer prevention.
    Huh WK, Kendrick JE, Alvarez RD.
    Obstet Gynecol; 2007 May 01; 109(5):1187-92. PubMed ID: 17470604
    [Abstract] [Full Text] [Related]

  • 37. [Human papillomavirus vaccines].
    Brun JL.
    J Gynecol Obstet Biol Reprod (Paris); 2008 Feb 01; 37 Suppl 1():S155-66. PubMed ID: 18187268
    [Abstract] [Full Text] [Related]

  • 38. Human papillomavirus vaccine for genotypes 6, 11, 16 and 18: new drug. Cervical cancer prevention: high hopes...
    Prescrire Int; 2007 Jun 01; 16(89):91-4. PubMed ID: 17582921
    [Abstract] [Full Text] [Related]

  • 39. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine.
    Goldie SJ, Grima D, Kohli M, Wright TC, Weinstein M, Franco E.
    Int J Cancer; 2003 Oct 10; 106(6):896-904. PubMed ID: 12918067
    [Abstract] [Full Text] [Related]

  • 40. Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.
    de Kok IM, van Ballegooijen M, Habbema JD.
    J Natl Cancer Inst; 2009 Aug 05; 101(15):1083-92. PubMed ID: 19571256
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.